lorazepam has been researched along with Respiratory Distress Syndrome, Newborn in 1 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Respiratory Distress Syndrome, Newborn: A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lorazepam was used to establish sedation and prevent asynchronous breathing while the infant was on the ventilator." | 1.29 | Lorazepam toxicity in a premature infant. ( Reiter, PD; Stiles, AD, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reiter, PD | 1 |
| Stiles, AD | 1 |
1 other study available for lorazepam and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Lorazepam toxicity in a premature infant.
Topics: Administration, Inhalation; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; | 1993 |